| Serial Number | 79315257 |
| Word Mark | OMERO |
| Filing Date | Tuesday, March 9, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 10, 2024 |
| Registration Number | 7497630 |
| Registration Date | Tuesday, September 10, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 1, 2022 |
| Goods and Services | Computer software that is downloaded and installed for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; computer software downloadable from the Internet for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science;data access and data management software tools that are downloaded and installed for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; downloadable electronic publications in the nature of scientific journals, periodicals and newsletters relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof |
| Goods and Services | Business services relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science, namely, management of biological and biomedical data and images for business enterprises; data processing services relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof |
| Translation of Words in Mark | The English translation of "OMERO" in the mark is "Humerus" or "Homer". |
| Goods and Services | Licensing of computer software for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof |
| Goods and Services | Design and development of computer software, data access and data management software tools for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; computer programming; installation, maintenance and repair of computer software; design of computer websites and maintenance thereof, all relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; software as a service (SAAS) featuring software for accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 26, 2021 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 26, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 26, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 26, 2021 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Glencoe Software Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98104-310 |
| Party Name | Glencoe Software Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98104-310 |
| Party Name | Glencoe Software Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98104-310 |
| Event Date | Event Description |
| Thursday, July 8, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, July 19, 2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Monday, July 26, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 30, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, October 4, 2021 | ASSIGNED TO EXAMINER |
| Thursday, October 7, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, November 8, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, October 8, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, November 9, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, November 29, 2021 | REFUSAL PROCESSED BY IB |
| Thursday, May 5, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, May 5, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, May 5, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, May 5, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, May 5, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, May 9, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, May 8, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, May 8, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 11, 2022 | FINAL REFUSAL WRITTEN |
| Wednesday, May 11, 2022 | FINAL REFUSAL E-MAILED |
| Wednesday, May 11, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, September 23, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 22, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, September 23, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 23, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 23, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 23, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 12, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, October 12, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, October 12, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, November 1, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 1, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, December 14, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, November 1, 2022 | NOTIFICATION PROCESSED BY IB |
| Monday, November 14, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, December 14, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, January 3, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Saturday, April 29, 2023 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
| Friday, August 2, 2024 | OPPOSITION DISMISSED NO. 999999 |
| Friday, August 2, 2024 | OPPOSITION TERMINATED NO. 999999 |
| Friday, August 2, 2024 | TTAB RELEASE CASE TO TRADEMARKS |
| Tuesday, September 10, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 10, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 30, 2023 | REFUSAL PROCESSED BY IB |
| Monday, May 1, 2023 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
| Wednesday, May 3, 2023 | OPPOSITION INSTITUTED NO. 999999 |